Latest Articles

Publication Date
[Comparative analysis of clinicopathological and molecular characteristics between pure ovarian endometrioid carcinoma and synchronous endometrial and ovarian endometrioid carcinoma].

Objective: To investigate the differences in clinicopathological and molecular characteristics between pure ovarian endometrioid carcinoma (POEC) and synchronous endometrial and ovarian endometrioid carcinoma (SEOEC), aiming to provide a basis for …

Published: Jan. 31, 2026, midnight
Complication Rates and Management in Sentinel Lymph Node Biopsy for Endometrial Cancer: A Retrospective Cohort Study - Frontiers

Complication Rates and Management in Sentinel Lymph Node Biopsy for Endometrial Cancer: A Retrospective Cohort Study Frontiers

Published: Jan. 30, 2026, 6:10 p.m.
Myriam Saadi: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited Settings - Oncodaily

Myriam Saadi: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited Settings Oncodaily

Published: Jan. 30, 2026, 5:27 p.m.
The silent symptoms of cervical cancer you need to monitor closely - InYourArea

The silent symptoms of cervical cancer you need to monitor closely InYourArea

Published: Jan. 30, 2026, 6:32 a.m.
Associations of Lipid Metabolism Abnormalities and Obesity With Endometriosis-Associated Ovarian Cancer.

To investigate the differences in lipid metabolism and obesity between patients with ovarian endometrioid carcinoma (OEC) and ovarian clear cell carcinoma (OCCC), both of which are classified as endometriosis-associated Type …

Published: Jan. 30, 2026, midnight
Relationship between serum CA125, prolactin and cortisol levels with disease stage and pain level in endometriosis patients.

Endometriosis affects approximately 10% of women of reproductive age and is characterized by the presence of endometrial tissue outside the uterine cavity. Diagnostic delays are common due to nonspecific symptoms …

Published: Jan. 30, 2026, midnight
Aprea Therapeutics Reports Early Clinical Activity of APR-1051 in Advanced Endometrial Cancer with Significant Tumor Reduction - Quiver Quantitative

Aprea Therapeutics Reports Early Clinical Activity of APR-1051 in Advanced Endometrial Cancer with Significant Tumor Reduction Quiver Quantitative

Published: Jan. 29, 2026, 1:31 p.m.
MCAZ warns public over unauthorised Zoladex cancer drug on market - NewZimbabwe.com

MCAZ warns public over unauthorised Zoladex cancer drug on market NewZimbabwe.com

Published: Jan. 29, 2026, midnight
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment - targetedonc.com

Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment targetedonc.com

Published: Jan. 28, 2026, 10:02 p.m.
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment - Targeted Oncology

Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment Targeted Oncology

Published: Jan. 28, 2026, 10:02 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!